Current and future public health is characterized by the increase of chronic and degenerative diseases, corresponding to the worldwide ageing of the population. The increasing prevalence of these conditions together with the long incubation period of the chronic diseases and the continual technological innovations, offer new opportunities to develop strategies for early diagnosis.
Public Health has an important mandate to critically assess the promises and the pitfalls of disease screening strategies. This MOOC will help you understand important concepts for screening programs that will be explored through a series of examples that are the most relevant to public health today. We will conclude with expert interviews that explore future topics that will be important for screening.
By the end of this MOOC, students should have the competency needed to be involved in the scientific field of screening, and understand the public health perspective in screening programs.
This MOOC has been designed by the University of Geneva and the University of Lausanne.
This MOOC has been prepared under the auspices of the Ecole romande de santé publique (www.ersp.ch) by Prof. Fred Paccaud, MD, MSc, Head of the Institute of Social and Preventive Medicine in Lausanne (www.iumsp.ch), in collaboration with Professor Antoine Flahault, MD, PhD, head of the Institute of Global Health, Geneva (https://www.unige.ch/medecine/isg/en/) and Prof. Gillian Bartlett-Esquilant (McGill University, Quebec/ Institute of Social and Preventive Medicine, Lausanne).

從本節課中

Evaluation, Planning, Implementation and the Future of Screening Programs

In this final module, important aspects of for the evaluation, planning and decision making about the implementation or stopping of screening programs will be presented. This material is given by Senior lecturer Jean-Luc Bulliard who is an epidemiologist in the Division of Chronic Diseases at the Institute for Social and Preventive Medicine in Lausanne. The conclusion of the module will be a series of interviews with experts on the future of disease screening in public health conducted by Dr. Gillian Bartlett-Esquilant, a visiting professor at the Institute for Social and Preventive Medicine at Lausanne. A quiz will close this module.

與講師見面

Antoine Flahault

Professor of Public Health and Director of the Institute of Global Health (Faculty of Medicine, University of Geneva) and co-Director of Centre Virchow-Villermé (Université Paris Descartes)University of Geneva and Université Paris Descartes – Sorbonne Paris Cité

Fred Paccaud (In Partnership with UNIGE)

Professor of epidemiology and public health and Director of the Institute of social and preventive medicineLausanne University Hospital

Gillian Bartlett-Esquilant

Professor of Epidemiology and Research and Graduate Program Director and Associate Chair for the Department of Family Medicine at McGill University.University of Lausannne and McGill University

Welcome to the last session for the course on disease screening in public health.

In this course, we have presented you with

the general concepts and metrics that are essential to screening.

We then provided several modules that explore different types of disease

screening at different times during the life course and in different environments.

We concluded with essential information needed for the evaluation,

planning, and implementation of screening programs.

The general purpose of the course was to increase the competency of people involved in

the scientific field of screening and to

put screening into the public health perspective.

You should now understand that you cannot consider only a screening test in isolation,

but must consider screening as an entire program that is complex and requires

careful evaluation and considered decisions by patients, providers, and policymakers.

In this final part of the last module,

I'll be interviewing several experts on what they feel will be

the future focus of disease screening and public health.

This will include an interview on the use of genomics

and screening for nutritional risk factors.

The second interview will address the use of

qualitative research to generate important evidence for evaluation,

planning, and implementation of screening programs.

The third and final interview will cover the interactions between public health and

primary care and how this relates to screening programs.

For our first interview.

We have Dr. Murielle Boshud,

who is the new head of the Institute for Social and Preventive Medicine.

Dr. Boshud will be speaking with us about the role of genomics in

screening as it relates to assessing nutritional risk factors.

Please tell us a little bit about yourself.

I am a public health physician and a genetic epidemiologist.

I do both public health research and services,

and my expertise is primarily in the field of genetic epidemiology and

nutrition epidemiology as well as cardiometabolic epidemiology.

Can you tell us what is meant by nutrigenomics?

Nutrigenomics is a field that looks at the interface between diet and

health while taking into account

genomic information or other omics information such as epigonomics, transcriptomics.

It is in the classical case,

the study of how genetic determinant influence the effect of

diet on human health and we can also envisage these fields.

Nowadays, with novel technological developments,

has a study of how nutrition influences health through modifications

of how the genome is expressed and what are the consequences on health.

How do you envision this being used in public health screening programs?

We are not yet ready for personalized nutrition recommendations.

Global recommendations that are targeted to the general population still remain valid.

That is, for instance,

to recommend people to eat plenty of fruits and

vegetables regardless of their genetic background.

However, we do know from

recent research findings that when given the same standardized meal,

different individuals will provide or display different metabolic responses.

It is possible that in the future,

nutrition recommendations become more

personalized and targeted to their genetic background.

But at the time being,

the evidence is not sufficient to do so.

What do you think will be the major challenges.

The major benefits?

I think the major challenges to implement the knowledge from nutrigenomics into

public health screening programs will be first to be able to handle

the huge amount of data that is needed to adequately interpret this information.

Another challenge is that diet is known to

influence health but it is likely that we need to

consider exposure to diet during

many years or even many decades before it has an impact on health.

So that we need to capture these long-term exposure

to diet during a very long period of time.

So one of the challenges to adequately capture

long-term diet and long-term exposure to selected nutrients for instance.

Current tools have important limitations.

For instance, food frequency questionnaires or 24-hour recalls,

as they are based on the fact that people do

remember what they ate usually or what they ate during the day before.

And if we want to have a long-written assessment,

we would need to repeat the use of such tools at regular intervals and

this would present a substantial burden to participants and also a high research cost.

So one of the challenge will be to develop methods that are not

too cumbersome for participants and that do not cost too much money,

so that we have a good assessment of exposure to diet

and can evaluate or analyze the impact on health.

Another challenge is that the relationship between diet and

human diseases is very complex and that there is still a lot

of knowledge that need to be acquired so that we

can then design and develop interventions

that are efficient in improving an individual's health status and prognosis.

It is also important to consider the entire food chain that is not only what people

eat but also how the food came to to the individuals,

and to ensure that the entire food production chain is

sustainable and also safe for people to consume.

So the relationship between nutrition and

human health is a very complex entity that will require

the multidisciplinary teams able to digest a huge amount of data and

also to get a better understanding of how human health can influence,

sorry, a better understanding of how nutrition can influence human health.

Currently many diseases are known to be strongly influenced by diet,

such diseases are cancer, cardiovascular disease,

metabolic diseases such as obesity and type 2 diabetes.

I'm convinced that when our knowledge will have improved,

we will be able to target nutritional interventions to the needs of

the individuals and therefore be more

efficient in fighting and better preventing those diseases.

We would like to thank Dr. Boshud for taking this time to share her views on

this interesting topic that we are sure to hear more about in the future.

For our next interview,

we have Professor Brenda Spencer,

who is the senior academic at the Institute for Social and Preventive Medicine.

Professor Spencer will be speaking with us about the role of

qualitative research and how it can contribute to

the generation of needed evidence for screening

program evaluation, planning, and implementation.

Please tell us a little bit about yourself.

My name is Brenda Spencer.

I originally trained in psychology and from then onwards,

I've spent on my professional life in public health.

I've specialized quite a lot in

sexual and reproductive health and in health promotion and then over recent years,

in fact for about the past 15 years,

I've developed a speciality in our institution to help

people conduct qualitative research in the field of clinical research.

Can you give us a short explanation of what qualitative research methods are?

Qualitative research is destined to answer questions such as why

and to explore issues as opposed to

quantitative research which we're more looking at the questions of how many.

So the things we know about in terms of methods that we usually

use interviewing and this is open interviewing,

be it on structured or semi-structured.

A lot of people have heard of the techniques of focus groups which are a kind of

collective interview and then observation whether

it's a participant or non-participant observation.

These are the main methods that we think about when we

talk about qualitative research methods.

Qualitative methods are often critical for implementation and program evaluation.

Can you provide some examples of how you think

qualitative research could improve public health screening programs?

When we set up a public health screening program,

we need to know that the program is accessible to

the target population and that it is acceptable to the target population.

To me, it's very difficult to answer

these questions if we don't do qualitative research because

otherwise we're assuming what the public see as being accessibility.

We're assuming that we know how they're thinking about things,

what will be their fears,

what will be their expectations,

all of these things we actually need to push them directly to understand these issues.

And we have learnt in the past from many screening programs,

over a number of years,

that sometimes we assume we know what the problem is when there's low uptake was,

in fact if we actually go and find out from the people

that we're working with and that we're hoping to attract,

the answers can be very different.

Many years ago, in pioneering days of screening programs,

I was involved in setting up what we called

provider-initiated, consumer-orientated screening program.

And for this, we needed to check how people were seeing what was being offered to them,

and examine exactly why people were not attending when they were attending.

And in that particular situation,

we learnt the problems that we thought were to do

with fears in the mind of the public were, in fact,

sometimes quite banal problems such as

the fact that the screening service was not open at the right kind of times,

and that it wasn't simply accessible to them.

In particular, in this case,

it was a question of accessibility to busy mothers.

So, in fact, what we need to do is go into these situations in order to check out what

is happening really directly rather than

projecting our own ideas and our own notions from the situation,

which, in fact, are very much related to our own perspective of the world.

We need to see what their perspective of the world is.

What do you think will be the major challenges?

The major benefits?

The major challenges to establishing

qualitative research in constructing screening programs.

Our field are actually challenges that come from the inside rather than from the outside.

And that we work in a field where the biomedical perspective is very much preponderant.

And in these situations, very often,

it is our own colleagues who don't understand what qualitative research can do and

the fact to establish a certain amount of

resistance or see these things as not very serious.

See them as not scientific.

And, in fact, they're the challenges that in fact we very often

meet for the researches that are involved in this kind of approach.

And there's the major benefit.

Well, I see qualitative research is being totally complementary to quantitative research.

The two work together and I think if we have a vision of integrating the two,

then this will carry substantial benefits,

which we can't have by just having one approach or the other.

So far, the issues that I've mentioned have been very much in

terms of thinking about how to implement programs.

In my institution, we're involved very heavily in evaluating programs,

and what we find is that systematically,

it's necessary to have a number of different approaches and to

triangulate questions in order to really get answers in complex situations.

In these complex situations, very often,

we have to look at what's happening with a number of different stakeholders.

And, in order to do this,

it's necessary to go and find out quite simply.

It's necessary to go and ask the questions and to strip to

the research around the answering of complex questions and evaluation.

I really don't feel that you can get the necessary answers

with just simple questionnaires and with simple counting.

I think you really have to dig underneath and find out what's going on,

find out what the problems are,

and find out how we can better meet the challenges at this level.

We'd like to thank Professor Spencer for taking the time to share her views on

this key research methodology that can help to provide

a solid evidence based for making decisions about screening programs in the future.

For our final interview,

we have Dr. Jacques Cornuz,

who is the head of the University Medical Polyclinic.

Dr. Cornuz will be speaking with us about the intersection of

primary care and public health and how this is important for screening.

Please tell us a little bit about yourself.

First, I got a degree in political sciences here in the University of Lausanne.

Then, I got MD degree also here in Lausanne and I decided then

to get the internal medicine training

in a hospital in ambulatory care settings in Switzerland.

Then I moved to the US to get MPH at

the Harvard School of Public Health in the concentration

of clinical effectiveness, clinical epidemiology.

And then I decided to came back

to Lausanne to get the faculty position here at the university hospital,

first as associate professor.

And from 2011 as full professor of

medicine and chief medical officer

of the Department of Ambulatory Care and Community Medicine.

I'm now deeply involved in teaching preventive medicine,

evidence-based medicine, and also general internal medicine here in Lausanne.

Can you give us a short explanation of

primary care and how it current relates to public health?

Primary care is the health care setting where the vast majority of

health issues are addressed among citizens for the general population.

And I do believe that primary care professionals and public health officers